LJMU Research Online

Heparan sulfate (HS) polysaccharides are ubiquitous components of the cell surface and extracellular matrix of all multicellular animals, whereas heparin is present within mast cells and can be viewed as a more sulfated, tissue-specific, HS variant. HS and heparin regulate biological processes through interactions with a large repertoire of proteins. Owing to these interactions and diverse effects observed during in vitro , ex vivo and in vivo experiments, manifold biological/pharmacological activities have been attributed to them. The properties that have been thought to bestow protein binding and biological activity upon HS and heparin vary from high levels of sequence specificity to a dependence on charge. In contrast to these opposing opinions, we will argue that the evidence supports both a level of redundancy and a degree of selectivity in the structure–activity relationship. The relationship between this apparent redundancy, the multi-dentate nature of heparin and HS polysaccharide chains, their involvement in protein networks and the multiple binding sites on proteins, each possessing different properties, will also be considered. Finally, the role of cations in modulating HS/heparin activity will be reviewed and some of the implications for structure–activity relationships and regulation will be discussed.

[1]  G. Balogh,et al.  Dynamic properties of the native free antithrombin from molecular dynamics simulations: computational evidence for solvent- exposed Arg393 side chain , 2015, Journal of biomolecular structure & dynamics.

[2]  J. Turnbull,et al.  Heparan sulfate phage display antibodies recognise epitopes defined by a combination of sugar sequence and cation binding. , 2015, Organic & biomolecular chemistry.

[3]  F. Lamari,et al.  HS3ST2 expression is critical for the abnormal phosphorylation of tau in Alzheimer's disease-related tau pathology. , 2015, Brain : a journal of neurology.

[4]  Marco Rusnati,et al.  Heparin/Heparan Sulfate Proteoglycans Glycomic Interactome in Angiogenesis: Biological Implications and Therapeutical Use , 2015, Molecules.

[5]  P. Meikle,et al.  Distribution of Heparan Sulfate Oligosaccharides in Murine Mucopolysaccharidosis Type IIIA , 2014, Metabolites.

[6]  A. Imberty,et al.  Importance of the polarity of the glycosaminoglycan chain on the interaction with FGF-1. , 2014, Glycobiology.

[7]  G. Torri,et al.  Antithrombin-binding oligosaccharides: structural diversities in a unique function? , 2014, Glycoconjugate Journal.

[8]  Yassir A. Ahmed,et al.  Characterisation of the interaction of neuropilin-1 with heparin and a heparan sulfate mimetic library of heparin-derived sugars , 2014, PeerJ.

[9]  J. Esko,et al.  Demystifying heparan sulfate-protein interactions. , 2014, Annual review of biochemistry.

[10]  E. Yates,et al.  A heparin-like glycosaminoglycan from shrimp containing high levels of 3-O-sulfated D-glucosamine groups in an unusual trisaccharide sequence. , 2014, Carbohydrate research.

[11]  R. Linhardt,et al.  Capillary electrophoresis for total glycosaminoglycan analysis , 2014, Analytical and Bioanalytical Chemistry.

[12]  Sylvie Ricard-Blum,et al.  Heparin-protein interactions: from affinity and kinetics to biological roles. Application to an interaction network regulating angiogenesis. , 2014, Matrix biology : journal of the International Society for Matrix Biology.

[13]  R. Linhardt,et al.  Fibroblast Growth Factor-based Signaling through Synthetic Heparan Sulfate Blocks Copolymers Studied Using High Cell Density Three-dimensional Cell Printing* , 2014, The Journal of Biological Chemistry.

[14]  J. Zaia,et al.  Brittlestars contain highly sulfated chondroitin sulfates/dermatan sulfates that promote fibroblast growth factor 2-induced cell signaling. , 2014, Glycobiology.

[15]  E. Yates,et al.  A non-hemorrhagic hybrid heparin/heparan sulfate with anticoagulant potential. , 2014, Carbohydrate polymers.

[16]  Q. Nunes,et al.  The heparin-binding protein interactome in pancreatic diseases. , 2013, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[17]  S. Perkins,et al.  The solution structure of heparan sulfate differs from that of heparin. IMPLICATIONS FOR FUNCTION. , 2013, The Journal of Biological Chemistry.

[18]  J. Zaia,et al.  Heparan sulfate-protein binding specificity , 2013, Biochemistry (Moscow).

[19]  J. Leary,et al.  Method development and analysis of free HS and HS in proteoglycans from pre- and postmenopausal women: evidence for biosynthetic pathway changes in sulfotransferase and sulfatase enzymes. , 2013, Analytical chemistry.

[20]  Jian Liu,et al.  An approach for separation and complete structural sequencing of heparin/heparan sulfate-like oligosaccharides. , 2013, Analytical chemistry.

[21]  J. Zaia,et al.  Comparative glycomics of leukocyte glycosaminoglycans , 2013, The FEBS journal.

[22]  D. Fernig,et al.  Analysis of the fibroblast growth factor receptor (FGFR) signalling network with heparin as coreceptor: evidence for the expansion of the core FGFR signalling network , 2013, The FEBS journal.

[23]  E. Yates,et al.  Antithrombin stabilisation by sulfated carbohydrates correlates with anticoagulant activity , 2013 .

[24]  Yunliang Chen,et al.  Perturbation of the heparin/heparin-sulfate interactome of human breast cancer cells modulates pro-tumourigenic effects associated with PI3K/Akt and MAPK/ERK signalling , 2013, Thrombosis and Haemostasis.

[25]  M. G. Maragheh,et al.  Evaluate of heavy metal concentration in shrimp (Penaeus semisulcatus) and crab (Portunus pelagicus) with INAA method , 2013, SpringerPlus.

[26]  Paul L. Dubin,et al.  Protein–polyelectrolyte interactions , 2013 .

[27]  C. Boudier,et al.  An unusual antithrombin-binding heparin octasaccharide with an additional 3-O-sulfated glucosamine in the active pentasaccharide sequence. , 2013, The Biochemical journal.

[28]  S. Hung,et al.  Divergent synthesis of 48 heparan sulfate-based disaccharides and probing the specific sugar-fibroblast growth factor-1 interaction. , 2012, Journal of the American Chemical Society.

[29]  G. Kellogg,et al.  On the Specificity of Heparin/Heparan Sulfate Binding to Proteins. Anion-Binding Sites on Antithrombin and Thrombin Are Fundamentally Different , 2012, PloS one.

[30]  Yassir A. Ahmed,et al.  Diversification of the Structural Determinants of Fibroblast Growth Factor-Heparin Interactions , 2012, The Journal of Biological Chemistry.

[31]  Yongmei Xu,et al.  Chemoenzymatic Synthesis of Heparin Oligosaccharides with both Anti-factor Xa and Anti-factor IIa Activities* , 2012, The Journal of Biological Chemistry.

[32]  I. Prior,et al.  Transport of Fibroblast Growth Factor 2 in the Pericellular Matrix Is Controlled by the Spatial Distribution of Its Binding Sites in Heparan Sulfate , 2012, PLoS biology.

[33]  C. Tucker,et al.  Fundamental differences in model cell-surface polysaccharides revealed by complementary optical and spectroscopic techniques , 2012 .

[34]  Yongmei Xu,et al.  Chemoenzymatic synthesis of heparan sulfate and heparin. , 2014, Natural product reports.

[35]  E. Yates,et al.  A highly efficient tree structure for the biosynthesis of heparan sulfate accounts for the commonly observed disaccharides and suggests a mechanism for domain synthesis. , 2012, Molecular bioSystems.

[36]  H. Nader,et al.  Chemical reduction of carboxyl groups in heparin abolishes its vasodilatory activity , 2012, Journal of cellular biochemistry.

[37]  M. Fini,et al.  Heparin-like heparan sulfate from rabbit cartilage. , 2012, Glycobiology.

[38]  N. Leymarie,et al.  Highly Sulfated Nonreducing End-derived Heparan Sulfate Domains Bind Fibroblast Growth Factor-2 with High Affinity and Are Enriched in Biologically Active Fractions* , 2011, The Journal of Biological Chemistry.

[39]  P. Seeberger,et al.  Characterization of annexin A1 glycan binding reveals binding to highly sulfated glycans with preference for highly sulfated heparan sulfate and heparin. , 2011, Biochemistry.

[40]  A. Ori,et al.  A Systems Biology Approach for the Investigation of the Heparin/Heparan Sulfate Interactome* , 2011, The Journal of Biological Chemistry.

[41]  M. Hricovíni Effect of solvent and counterions upon structure and NMR spin-spin coupling constants in heparin disaccharide. , 2011, The journal of physical chemistry. B.

[42]  A. Ori,et al.  Comparable stabilisation, structural changes and activities can be induced in FGF by a variety of HS and non-GAG analogues: implications for sequence-activity relationships. , 2010, Organic & biomolecular chemistry.

[43]  E. Yates,et al.  The latent ampholytic nature of glycosaminoglycan (GAG) oligosaccharides facilitates their separation by isoelectric focusing , 2010 .

[44]  P. Dubin,et al.  Glycosaminoglycans as polyelectrolytes. , 2010, Advances in colloid and interface science.

[45]  D. Spillmann,et al.  Heparan Sulfate Domain Organization and Sulfation Modulate FGF-induced Cell Signaling* , 2010, The Journal of Biological Chemistry.

[46]  E. Yates,et al.  Conformational degeneracy restricts the effective information content of heparan sulfate. , 2010, Molecular bioSystems.

[47]  Yassir A. Ahmed,et al.  Generating heparan sulfate saccharide libraries for glycomics applications , 2010, Nature Protocols.

[48]  Jayesh Gor,et al.  Semi-rigid solution structures of heparin by constrained X-ray scattering modelling: new insight into heparin-protein complexes. , 2010, Journal of molecular biology.

[49]  H. Nader,et al.  Heparan sulfate proteoglycans: structure, protein interactions and cell signaling. , 2009, Anais da Academia Brasileira de Ciencias.

[50]  A. Ori,et al.  Cations modulate polysaccharide structure to determine FGF-FGFR signaling: a comparison of signaling and inhibitory polysaccharide interactions with FGF-1 in solution. , 2009, Biochemistry.

[51]  Umesh R Desai,et al.  Interaction of Antithrombin with Sulfated, Low Molecular Weight Lignins , 2009, The Journal of Biological Chemistry.

[52]  Jamie M. Verheyden,et al.  FGF-regulated Etv genes are essential for repressing Shh expression in mouse limb buds. , 2009, Developmental cell.

[53]  T. Dierks,et al.  Sulf Loss Influences N-, 2-O-, and 6-O-Sulfation of Multiple Heparan Sulfate Proteoglycans and Modulates Fibroblast Growth Factor Signaling* , 2008, Journal of Biological Chemistry.

[54]  Kimberly Forsten-Williams,et al.  Control of Growth Factor Networks by Heparan Sulfate Proteoglycans , 2008, Annals of Biomedical Engineering.

[55]  C. Boudier,et al.  Antithrombin-binding Octasaccharides and Role of Extensions of the Active Pentasaccharide Sequence in the Specificity and Strength of Interaction , 2008, Journal of Biological Chemistry.

[56]  D. Clarke,et al.  Site-specific interactions of copper(II) ions with heparin revealed with complementary (SRCD, NMR, FTIR and EPR) spectroscopic techniques. , 2008, Carbohydrate research.

[57]  A. Ori,et al.  The heparanome and regulation of cell function: structures, functions and challenges. , 2008, Frontiers in bioscience : a journal and virtual library.

[58]  D. Clarke,et al.  Influence of substitution pattern and cation binding on conformation and activity in heparin derivatives. , 2007, Glycobiology.

[59]  S. Werner,et al.  Potentiation of fibroblast growth factor activity by synthetic heparin oligosaccharide glycodendrimers. , 2007, Chemistry & biology.

[60]  P. Dubin,et al.  Nonspecific electrostatic binding characteristics of the heparin-antithrombin interaction. , 2007, Biopolymers.

[61]  Thomas Dierks,et al.  The heparanome--the enigma of encoding and decoding heparan sulfate sulfation. , 2007, Journal of biotechnology.

[62]  Diane J. Rodi,et al.  X-ray fluorescence microscopy reveals large-scale relocalization and extracellular translocation of cellular copper during angiogenesis , 2007, Proceedings of the National Academy of Sciences.

[63]  A. Dell,et al.  N-Glycosylation of Fibroblast Growth Factor Receptor 1 Regulates Ligand and Heparan Sulfate Co-receptor Binding* , 2006, Journal of Biological Chemistry.

[64]  M. Pardue,et al.  The Journal of Cell Biology , 2002 .

[65]  T. Peretz,et al.  Heparanase promotes growth, angiogenesis and survival of primary breast tumors , 2006, International journal of cancer.

[66]  Serge Pérez,et al.  Prospects for glycoinformatics. , 2005, Current opinion in structural biology.

[67]  M. Nugent,et al.  Identification of common and specific growth factor binding sites in heparan sulfate proteoglycans. , 2005, Biochemistry.

[68]  P. Dubin,et al.  Characterization of polyanion-protein complexes by frontal analysis continuous capillary electrophoresis and small angle neutron scattering: effect of polyanion flexibility. , 2005, Analytical biochemistry.

[69]  P. Jemth,et al.  Fibroblast growth factors share binding sites in heparan sulphate. , 2005, The Biochemical journal.

[70]  I. Vlodavsky,et al.  In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[71]  R. Linhardt,et al.  Structural characterization of human liver heparan sulfate. , 2005, Biochimica et biophysica acta.

[72]  T. Peretz,et al.  Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis. , 2004, Journal of the National Cancer Institute.

[73]  S. Oscarson,et al.  Irreversible Glucuronyl C5-epimerization in the Biosynthesis of Heparan Sulfate* , 2004, Journal of Biological Chemistry.

[74]  J. Kiss,et al.  VEGF is a chemoattractant for FGF-2–stimulated neural progenitors , 2003, The Journal of cell biology.

[75]  L. Bain,et al.  Altered expression of sulfotransferases, glucuronosyltransferases and mrp transporters in FVB/mrp1–/– mice , 2003, Xenobiotica; the fate of foreign compounds in biological systems.

[76]  B. L. Allen,et al.  Spatial and temporal expression of heparan sulfate in mouse development regulates FGF and FGF receptor assembly , 2003, The Journal of cell biology.

[77]  J. Huntington,et al.  Crystal structure of antithrombin in a heparin-bound intermediate state. , 2003, Biochemistry.

[78]  M. Lyon,et al.  Hepatocyte growth factor/scatter factor and its interaction with heparan sulphate and dermatan sulphate. , 2003, Biochemical Society transactions.

[79]  C. Tribet,et al.  Ionic strength dependence of protein-polyelectrolyte interactions. , 2003, Biomacromolecules.

[80]  P. Jemth,et al.  Biosynthetic Oligosaccharide Libraries for Identification of Protein-binding Heparan Sulfate Motifs , 2002, The Journal of Biological Chemistry.

[81]  M. Gasset,et al.  Prion protein interaction with glycosaminoglycan occurs with the formation of oligomeric complexes stabilized by Cu(II) bridges. , 2002, Journal of molecular biology.

[82]  D. Rabenstein Heparin and heparan sulfate: structure and function. , 2002, Natural product reports.

[83]  L. Lay,et al.  Minimal heparin/heparan sulfate sequences for binding to fibroblast growth factor-1. , 2002, Biochemical and biophysical research communications.

[84]  R. Linhardt,et al.  Heparin-protein interactions. , 2002, Angewandte Chemie.

[85]  D. Ron,et al.  Differential Effects of Heparin Saccharides on the Formation of Specific Fibroblast Growth Factor (FGF) and FGF Receptor Complexes* , 2002, The Journal of Biological Chemistry.

[86]  G. Giménez-Gallego,et al.  Sequence Analysis of Heparan Sulfate Epitopes with Graded Affinities for Fibroblast Growth Factors 1 and 2* , 2001, The Journal of Biological Chemistry.

[87]  J. Gallagher Heparan sulfate: growth control with a restricted sequence menu. , 2001, The Journal of clinical investigation.

[88]  J. Esko,et al.  Molecular diversity of heparan sulfate. , 2001, The Journal of clinical investigation.

[89]  B. Mulloy,et al.  Characterization of Unfractionated Heparin: Comparison of Materials from the last 50 Years , 2000, Thrombosis and Haemostasis.

[90]  M. Forster,et al.  Conformation and dynamics of heparin and heparan sulfate. , 2000, Glycobiology.

[91]  R. Vivès,et al.  Regulation of FGF-1 mitogenic activity by heparan sulfate oligosaccharides is dependent on specific structural features: differential requirements for the modulation of FGF-1 and FGF-2. , 2000, Glycobiology.

[92]  David F. Burke,et al.  Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin , 2000, Nature.

[93]  B. Snel,et al.  STRING: a web-server to retrieve and display the repeatedly occurring neighbourhood of a gene. , 2000, Nucleic acids research.

[94]  J. Schlessinger,et al.  Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. , 2000, Molecular cell.

[95]  H. Nader,et al.  A novel heparan sulphate with high degree of N-sulphation and high heparin cofactor-II activity from the brine shrimp Artemia franciscana. , 2000, International journal of biological macromolecules.

[96]  A. Friedl,et al.  Differential ability of heparan sulfate proteoglycans to assemble the fibroblast growth factor receptor complex in situ , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[97]  J. Turnbull,et al.  Fibroblast growth factor receptor signalling is dictated by specific heparan sulphate saccharides , 1999, Current Biology.

[98]  S. Stringer,et al.  Heparin Is a Unique Marker of Progenitors in the Glial Cell Lineage* , 1999, The Journal of Biological Chemistry.

[99]  P. Gorin,et al.  Structural features and anticoagulant activities of a novel natural low molecular weight heparin from the shrimp Penaeus brasiliensis. , 1999, Biochimica et biophysica acta.

[100]  R. Pettersson,et al.  Characterization of fibroblast growth factor 1 binding heparan sulfate domain. , 1999, Glycobiology.

[101]  B. Seaton,et al.  Interaction of heparin with annexin V , 1999, FEBS letters.

[102]  D. Hart,et al.  The salt dependence of DNA recognition by NF-kappaB p50: a detailed kinetic analysis of the effects on affinityand specificity. , 1999, Nucleic acids research.

[103]  M. Porcionatto,et al.  Stimulation of heparan sulfate proteoglycan synthesis and secretion during G1 phase induced by growth factors and PMA , 1998, Journal of cellular biochemistry.

[104]  J. Turnbull,et al.  Heparan Sulfate Oligosaccharides Require 6-O-Sulfation for Promotion of Basic Fibroblast Growth Factor Mitogenic Activity* , 1998, The Journal of Biological Chemistry.

[105]  U. Desai,et al.  Mechanism of heparin activation of antithrombin: evidence for an induced-fit model of allosteric activation involving two interaction subsites. , 1998, Biochemistry.

[106]  M. Porcionatto,et al.  Structure of heparan sulfate: identification of variable and constant oligosaccharide domains in eight heparan sulfates of different origins. , 1998, Cellular and molecular biology.

[107]  P. Rudland,et al.  Interactions of putative heparin-binding domains of basic fibroblast growth factor and its receptor, FGFR-1, with heparin using synthetic peptides , 1998, Glycoconjugate Journal.

[108]  P. Rudland,et al.  Interaction of Heparan Sulfate from Mammary Cells with Acidic Fibroblast Growth Factor (FGF) and Basic FGF , 1998, The Journal of Biological Chemistry.

[109]  J. Hirsh,et al.  Effect of nonspecific binding to plasma proteins on the antithrombin activities of unfractionated heparin, low-molecular-weight heparin, and dermatan sulfate. , 1997, Circulation.

[110]  E. Yates,et al.  1H and 13C NMR spectral assignments of the major sequences of twelve systematically modified heparin derivatives. , 1996, Carbohydrate research.

[111]  J. Gabriel,et al.  Divalent Cations and Heparin/Heparan Sulfate Cooperate to Control Assembly and Activity of the Fibroblast Growth Factor Receptor Complex* , 1996, The Journal of Biological Chemistry.

[112]  C. MacArthur,et al.  Receptor Specificity of the Fibroblast Growth Factor Family* , 1996, The Journal of Biological Chemistry.

[113]  G. Torri,et al.  Characterization of sulfation patterns of beef and pig mucosal heparins by nuclear magnetic resonance spectroscopy. , 1996, Arzneimittel-Forschung.

[114]  D C Rees,et al.  Heparin Structure and Interactions with Basic Fibroblast Growth Factor , 1996, Science.

[115]  J. Peng,et al.  Multinuclear magnetic resonance studies of the interaction of inorganic cations with heparin. , 1995, Carbohydrate research.

[116]  J. Weiler,et al.  Differences in the interaction of heparin with arginine and lysine and the importance of these basic amino acids in the binding of heparin to acidic fibroblast growth factor. , 1995, Archives of biochemistry and biophysics.

[117]  M. Porcionatto,et al.  Heparan sulfate proteoglycan and control of cell proliferation: enhanced synthesis induced by phorbol ester (PMA) during G(1)-phase. , 1994, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[118]  J. Turnbull,et al.  Cell surface syndecan-1 on distinct cell types differs in fine structure and ligand binding of its heparan sulfate chains. , 1994, The Journal of biological chemistry.

[119]  M. Lyon,et al.  Liver heparan sulfate structure. A novel molecular design. , 1994, The Journal of biological chemistry.

[120]  M. Pantoliano,et al.  Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain. , 1994, Biochemistry.

[121]  G. Hortin,et al.  Interference in ionized calcium measurements by heparin salts. , 1994, Clinical chemistry.

[122]  J. Turnbull,et al.  Specific heparan sulfate saccharides mediate the activity of basic fibroblast growth factor. , 1994, The Journal of biological chemistry.

[123]  B. Olwin,et al.  Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4. , 1993, The Journal of biological chemistry.

[124]  Â. Gambarini,et al.  Mitogenic activity of acidic fibroblast growth factor is enhanced by highly sulfated oligosaccharides derived from heparin and heparan sulfate , 1993, Molecular and Cellular Biochemistry.

[125]  J. Turnbull,et al.  Heparan sulphate: functional role as a modulator of fibroblast growth factor activity. , 1993, Biochemical Society transactions.

[126]  S. Pizzo,et al.  Ionic modulation of the effects of heparin on plasminogen activation by tissue plasminogen activator: the effects of ionic strength, divalent cations, and chloride. , 1992, Archives of biochemistry and biophysics.

[127]  D. Grant,et al.  A potentiometric titration study of the interaction of heparin with metal cations. , 1992, The Biochemical journal.

[128]  J. Turnbull,et al.  Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate. , 1992, The Journal of biological chemistry.

[129]  R. Rej,et al.  Sulfation of some chemically-modified heparins. Formation of a 3-sulfate analog of heparin. , 1991, Carbohydrate research.

[130]  B. Casu,et al.  Structure of Heparin and Heparin Fragments , 1989, Annals of the New York Academy of Sciences.

[131]  D. Atha,et al.  Contribution of 3-O- and 6-O-sulfated glucosamine residues in the heparin-induced conformational change in antithrombin III. , 1987, Biochemistry.

[132]  H. Nader,et al.  Heparin sequences in the heparan sulfate chains of an endothelial cell proteoglycan. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[133]  H. Nader,et al.  Lack of correlation between "in vitro" and "in vivo" antithrombotic activity of heparin fractions and related compounds. Heparan sulfate as an antithrombotic agent "in vivo". , 1985, Thrombosis research.

[134]  D. Atha,et al.  Contribution of monosaccharide residues in heparin binding to antithrombin III. , 1985, Biochemistry.

[135]  J. Gallagher,et al.  Molecular distinctions between heparan sulphate and heparin. Analysis of sulphation patterns indicates that heparan sulphate and heparin are separate families of N-sulphated polysaccharides. , 1985, The Biochemical journal.

[136]  H. Nader,et al.  An inverse relationship between heparin content and antibody response in genetically selected mice. Sex effect and evidence of a polygenic control for skin heparin concentration. , 1984, The Biochemical journal.

[137]  P. Gullino,et al.  Angiogenesis in vivo and selective mobilization of capillary endothelium in vitro by heparin-copper complex. , 1984, Microcirculation, endothelium, and lymphatics.

[138]  A. Sartorelli,et al.  Incorporation of 35S-sulfate and 3H-glucosamine into heparan and chondroitin sulfates during the cell cycle of B16-F10 cells. , 1984, Cytometry.

[139]  M. Griffith,et al.  Calcium inhibits the heparin-catalyzed antithrombin III/thrombin reaction by decreasing the apparent binding affinity of heparin for thrombin. , 1983, Archives of biochemistry and biophysics.

[140]  H. Magdelenat,et al.  Effect of ionic strength on the diffusion coefficient of chondroitin sulfate and heparin measured by quasielastic light scattering , 1983 .

[141]  P. Ander,et al.  Sodium ion diffusion in aqueous salt-free heparin solutions , 1981 .

[142]  R. Rosenberg,et al.  Correlation between structure and function of heparin. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[143]  G. S. Manning The molecular theory of polyelectrolyte solutions with applications to the electrostatic properties of polynucleotides , 1978, Quarterly Reviews of Biophysics.

[144]  H. Nader,et al.  The heterogeneity of heparan sulfate from beef-lung tissue: p.m.r.-spectral evidence. , 1975, Carbohydrate research.

[145]  R. Tobey,et al.  CELL-CYCLE DEPENDENT DESQUAMATION OF HEPARAN SULFATE FROM THE CELL SURFACE , 1972, The Journal of cell biology.

[146]  D. Mackie,et al.  Evidence for a (1→4)-linked 4-O-(α-L-idopyranosyluronic acid 2-sulfate)-(2-deoxy-2-sulfoamino-D-glucopyranosyl 6-sulfate) sequence in heparin , 1971 .

[147]  D. F. Koenig,et al.  Structure of Hen Egg-White Lysozyme: A Three-dimensional Fourier Synthesis at 2 Å Resolution , 1965, Nature.

[148]  C. Boudier,et al.  Heparin Dodecasaccharide Containing Two Antithrombin-binding Pentasaccharides STRUCTURAL FEATURES AND BIOLOGICAL PROPERTIES , 2013 .

[149]  U. Lindahl,et al.  Interactions between heparan sulfate and proteins-design and functional implications. , 2009, International review of cell and molecular biology.

[150]  B. Mulloy The specificity of interactions between proteins and sulfated polysaccharides. , 2005, Anais da Academia Brasileira de Ciencias.

[151]  J. Turnbull,et al.  Highly diverse heparan sulfate analogue libraries: providing access to expanded areas of sequence space for bioactivity screening. , 2004, Journal of Medicinal Chemistry.

[152]  J. Angulo,et al.  The heparin-Ca(2+) interaction: Structure of the Ca(2+) binding site , 2002 .

[153]  B. Seaton,et al.  Annexin V--heparin oligosaccharide complex suggests heparan sulfate--mediated assembly on cell surfaces. , 2001, Structure.

[154]  S. Guimond,et al.  Heparan sulfate: decoding a dynamic multifunctional cell regulator. , 2001, Trends in cell biology.

[155]  U Lindahl,et al.  Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor. , 1994, The Journal of biological chemistry.

[156]  H. Kingdon,et al.  Effect of monovalent cations on the heparin-enhanced antithrombin III/thrombin reaction. , 1980, Thrombosis research.

[157]  Y. Inoue,et al.  Selective N-desulfation of heparin with dimethyl sulfoxide containing water or methanol. , 1976, Carbohydrate research.

[158]  D. Mackie,et al.  Evidence for a (1 leads to 4)-linked 4-O-( -L-idopyranosyluronic acid 2-sulfate)-(2-deoxy-2-sulfoamino-D-glucopyranosyl 6-sulfate) sequence in heparin. Long-range H-H coupling in 4-deoxy-hex-4-enopyranosides. , 1971, Carbohydrate research.